澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.

Clin. Cancer Res.. 2016-02; 
Romick-RosendaleLindsey E,HoskinsElizabeth E,Privette VinnedgeLisa M,FoglesongGrant D,BrusadelliMarion G,PotterS Steven,KomurovKakajan,BrugmannSamantha A,LambertPaul F,KimpleRandall J,VirtsElizabeth L,HanenbergHelmut,GillisonMaura L,WellsSusan
Products/Services Used Details Operation
Custom Vector Construction The MIEG-HPV-16-E7 (GenScript Piscataway, NJ) construct was developed from the pMIEG3 retroviral vector...The PCR product was produced, cut, and inserted into the EcoRI and XhoI sites in the pMIEG vector by GenScript. Get A Quote

摘要

Head and neck squamous cell carcinoma (HNSCC) remains a devastating disease, and Fanconi anemia (FA) gene mutations and transcriptional repression are common. Invasive tumor behavior is associated with poor outcome, but relevant pathways triggering invasion are poorly understood. There is a significant need to improve our understanding of genetic pathways and molecular mechanisms driving advanced tumor phenotypes, to develop tailored therapies. Here we sought to investigate the phenotypic and molecular consequences of FA pathway loss in HNSCC cells.

关键词